Allianz Asset Management’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
Other funds holding TWST
AIM
EIG
NAMA
Allianz Asset Management's TWST Position: Q2 2025 in Review
Allianz Asset Management sold out of Twist Bioscience (TWST) in Q2 2025, closing a stake of 17,000 shares — an estimated $667K sold.
Allianz Asset Management first reported a position in TWST in Q3 2019 and held it in 16 quarters. The position peaked at $220M in Q2 2021. 244 funds tracked by Wall St. Rank hold TWST as of Q2 2025.
- Allianz Asset Management reported no remaining Twist Bioscience position as of Q2 2025 after selling out during the quarter.
- Allianz Asset Management sold 17,000 Twist Bioscience shares in Q2 2025, an estimated $667K.
- Allianz Asset Management first reported a position in Twist Bioscience in Q3 2019 and held it in 16 quarters.
- Allianz Asset Management's Twist Bioscience position peaked at $220M in Q2 2021.
- 244 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2025.
Based on Allianz Asset Management's 13F filing for Q2 2025, filed 28 Jul 2025.